Boston Scientific (BSX) PT Raised to $120 at Truist; 'We Think '25 Guide Has Room for Upside'
Tweet Send to a Friend
Truist Securities analyst Richard Newitter raised the price target on Boston Scientific (NYSE: BSX) to $120.00 (from $110.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
